CONTACT US   |  (864) 397-5101

Nephron Opens Pediatric COVID-19 Vaccine Clinic

As children ages 5 to 11 become eligible for COVID-19 vaccines, Nephron Pharmaceuticals Corporation has announced the opening of a pediatric COVID-19 vaccine clinic at its vaccination drive-thru in West Columbia. The clinic is open Monday – Friday from 12:00 PM – 5:30 PM.

Nephron, in partnership with Dominion Energy South Carolina, launched a convenient drive-thru COVID-19 vaccination site earlier this year. The drive-thru is located on Dominion Energy property off of I-77 at Exit 2. In addition to providing the space for a drive-thru, Dominion Energy is also generously contributing power and logistics support.

As a part of its ongoing efforts to help respond to the COVID-19 pandemic, Nephron offers Pfizer and Moderna vaccinations to citizens, including those ages 5 to 11, who are eligible. This includes regular doses and boosters for adults, during regular hours, which remain Monday – Friday from 10:00 AM – 4:00 PM.

Nephron registered nurses and pharmacists are administering vaccinations, with assistance from Nephron CLIA-certified diagnostics lab employees.

COVID-19 tests are also available as a part of the drive-thru. Nephron established a diagnostics lab last year in order to conduct COVID-19 tests. Since opening the lab, Nephron has tested thousands of people across the state for COVID-19 – including employees, students, educators, athletes and families – as the company does its part to keep South Carolina healthy and safe during the public health crisis. The Nephron CLIA-certified lab procured state-of-the-art technology for COVID-19 real-time PCR testing and serological antibody testing. Results are delivered within 24-48 hours.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.